• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Data Science Startup Apixio Nabs $19M for Cognitive Computing Platform

by Jasmine Pennic 05/24/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Apixio

Healthcare data science company Apixio Inc., today announced that it has raised $19.3 million in Series D funding led by SSM Partners with participation from First Analysis, Bain Capital Ventures and Apixio’s largest angel investor. Apixio will utilize the funding towards advancing and scaling products powered by its cognitive computing platform, further enabling insights for optimal patient care. Casey West, managing partner at SSM Partners will join the Board of Directors, bringing deep healthcare expertise and data science knowledge. The latest Series D round bring the company’s total funding to date at $41.88M. 

Founded in 2009, Apixio’s cognitive computing platform uses proprietary data extraction tools and machine learning algorithms to create a self-learning system. Powered by its platform, the HCC Profiler solution mines clinical charts and medical billing data to accurately compute patient risk scores three times faster than traditional chart review methods. HCC Profiler now serves 22 customers, as healthcare insurance companies and provider groups increasingly recognize the need for an accurate view of patient conditions to better coordinate and deliver care.

Over the past year, Apixio has continued to unveil new features for its HCC Profiler solution, elevating the accuracy and speed of medical chart review to unprecedented levels. The platform has analyzed data from more than six million patients, achieving 210 percent year-over-year growth in patients analyzed.  

“Not only does Apixio automate the risk adjustment process and ensure accuracy and speed, but it does so in the face of massive healthcare changes,” said Jennifer Pereur, Director of Government Programs at Hill Physicians Medical Group. “Risk adjustment has gone through big changes in the past year including proposed changes to the audit program and significant increases in the number of Medicare Advantage patients. With Apixio, we can stay ahead of these changes and continue to turn elusive data into the catalyst for personalized care.”

 As the healthcare industry shifts toward value-based care, there is a greater need to transform previously unusable data into actionable insights. Startups like Apixio and others are poised to gain market share in this growing sector. According to Grand View Research, cloud computing technologies market is expected to reach $5 billion by 2022.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Apixio

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

mount-sinai-launches-epic-chart-with-art-nursing-ambient-ai

Mount Sinai Medical Center Extends Epic’s Ambient AI to Inpatient Nursing

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

Why Brain Health Is Entering Its Infrastructure Era

Brain Health’s Infrastructure Era: Proving Clinical Outcomes with Integrated Neuromotor Tracking

Why Catholic Health Inked a $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

Catholic Health Inks $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

M&A: ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $450M

M&A: ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $450M

The Real Risk in Healthcare AI Isn’t the Model. It’s the Data. 

Clinical Data Fidelity: The Real Blindspot in Healthcare AI Strategy

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |